← Back to news

Markets

Street Confidence Builds as Autodesk, Inc. (ADSK) Gains Enterprise Traction

Y

Commvault Systems, Inc. (CVLT) Ranks Among Top Digital Infrastructure Performers

Y

Dave Inc. (DAVE) Is a “highly profitable neobank” Platform, Says Keefe, Bruyette & Woods

Y

Analysts Bullish On AppLovin Corporation (APP) Outlook Following Impressive Results

Y

Chewy, Inc. (CHWY) Near 52-Week Low, Yet Street Stays Bullish

Y

What Analysts Think About GoDaddy Inc. (GDDY)

Y

“A Super Simple Short Thesis” Targets Super Group (SGHC) Limited (SGHC) Shares

Y

Is Duolingo, Inc. (DUOL) The Best Money-making Stock To Buy Right Now?

Y

CSPF: Attractive New Active Preferred Equity ETF From Cohen

S

Why Apple No Longer Trades Like a Tech Firm

Y

Wall Street’s AI Anxiety-Induced Software Selloff Gets a Reality Check

Y

What Can You Do With RMDs If You Don't Need the Income?

Y

US stocks slip as AI fears keep rumbling and oil prices climb

Y

India's Tata signs up OpenAI as customer for data centre business

Y

It Is a Stock Picker's Market, Pepperstone's Weston Says

Y

The 2026 Software Stock Sell-Off: AI Disruption Fear, Broken Logic, or Something Else Entirely?

Y

Kirin's Yoshimura on Health Science Business Strategy

Y

What I'm Watching With CubeSmart Stock To See If It Beats The Market

Y

Evercore Notes AbbVie Inc.’s (ABBV) Tremfya Gains Market Share, But Future Earnings Growth May Be Limited

Y

Needham Bullish on Neurocrine Biosciences, Inc. (NBIX) Pipeline Amid 2026 Growth Expectations for Crenessity and Ingrezza

Y

Jefferies Assigns 65–75% Probability of Best-in-Class Efficacy for Definium Therapeutics, Inc.’s (DFTX) DT120 in Phase III

Y

Analysts Bullish on COMPASS Pathways plc (CMPS) Following Psychedelics Symposium and Model Updates

Y

Baird Lowers Bright Minds Biosciences Inc. (DRUG) Price Target to $126, Maintains Outperform Rating Ahead of Upcoming Trials

Y

Jeffries Highlight Cybin D/B/A Helus Pharma (HELP)’s Science-Driven Psilocybin Therapies as Key Growth Drivers

Y

RBC Capital Cite GH Research PLC’s (GHRS) Long-Term Sales Potential Following Psychedelics Symposium

Y

Edison International Posts Strong 2025 and Sets 2026–2027 EPS Targets

Y

VivoPower $30M PIPE deal fuels AI data centre growth

Y

Target expands stores as customers get fed up with chaos

Y

Joe Rogan Says Warren Buffett, George Soros Are 'Not As Good As' Nancy Pelosi's Husband In Stock Trading, Thinks Politicians 'Know Something'

Y

IRS Grants Tech, Pharma a Tax Break Boost From Trump Deduction

Y

Goldman Sachs See Teva Pharmaceutical Industries Limited (TEVA) Driving Double-Digit Earnings Growth Through 2026

Y

2 Utility Stocks to Buy in February

Y

Rising Energy Demand Will Lift This Stock

Y

Cognex CFO Sees Demand Improving but Wants More Proof of a Durable Upcycle at Conference

Y

What Does the Average Retiree Really Get From Social Security?

Y

Before you buy the software and Big Tech dips, take a closer look at this overseas stock market

Y

Bitcoin Caught Between Hawkish Fed and Dovish Warsh

Y

Occidental Cuts Debt and Lifts Dividend After OxyChem Sale

Y

2 Top Artificial Intelligence Stocks to Buy in February

Y

TrueBlue, Inc. Q4 2025 Earnings Call Summary

Y

Rogers Corporation Q4 2025 Earnings Call Summary

Y

Nextdoor Holdings, Inc. Q4 2025 Earnings Call Summary

Y

Jack in the Box Inc. Q1 2026 Earnings Call Summary

Y

Clearwater Paper Corporation Q4 2025 Earnings Call Summary

Y

Where Will Micron Stock Be in 5 Years?

Y

After Years of Buybacks, Big Oil is Drilling Again

Y

Why Applovin Stock Popped Today

Y

TD Cowen Lowers Aurora Innovation (AUR) PT, Cites Soft 2026 Guidance Despite Growth Inflection Outlook

Y

Morgan Stanley Names Rocket Pharmaceuticals (RCKT) as Key Beneficiary of 2026 Biotech Sector Recovery

Y